COVID-19 survey among people who use drugs in three cities in Norway.

COVID-19 survey among people who use drugs in three cities in Norway.
复制标题

DOI:
10.1016/j.drugalcdep.2020.108302
复制
发表时间:
2020-12-01
影响因子:
4.2
通讯作者:
Gjersing L
Gjersing L
中科院分区:
医学2区
文献类型:
--
作者:
Welle-Strand GK;Skurtveit S;Clausen T;Sundal C;Gjersing L

文献摘要

参考文献

被引文献

相似文献

关于使用药物的人(PWUD)对COVID-19相关问题以及由于COVID-19导致的药物市场变化的了解甚少。因此,我们进行了一项调查,以探讨这些问题。在一项横断面研究中,我们于2020年5月/6月访问了来自挪威三个城市的226名PWUD。参与者完成了一个采访管理的问卷调查。三个独立的多元二元逻辑回归模型估计的结果(否/是):1。熟悉COVID-19症状,2.了解为PWUD量身定制的COVID-19服务,以及3.愿意接受COVID-19检测。平均年龄为44.1岁,73%为男性。54%是注射者,海洛因/其他类阿片(35.8%)和可卡因/苯丙胺(25.2%)是最常见的主要毒品。总体而言,54.9%的患者接受阿片类药物维持治疗(OMT)。大多数人(65.9%)表示他们知道COVID-19的症状。几乎所有参与者(91.2%)都报告说,如果出现相关症状,他们会接受COVID-19检测。大多数(63.7%)不知道PWUD可获得的COVID-19服务。OMT患者更有可能熟悉COVID-19症状(aOR = 3.4,95% CI 1.7; 6.8),并了解COVID-19服务(aOR = 2.7,95% CI 1.1; 6.3)。总体而言,35.4%的人报告药物供应减少,主要是镇静剂,而61.5%的人报告药物价格上涨,主要是大麻。药物治疗可能在COVID-19预防中发挥重要作用,因为OMT患者更有可能意识到症状和服务的可用性。
Little is known regarding what people who use drugs (PWUD) know about COVID-19 related issues and changes in the drug market due to COVID-19. We therefore conducted a survey to explore these issues. In a cross-sectional study, we interviewed 226 PWUD from three Norwegian cities in May/June 2020. Participants completed an interview-administrated questionnaire. Three separate multiple binary logistic regression models were estimated with the outcomes (no/yes): 1. Familiarity with COVID-19 symptoms, 2. Awareness of COVID-19 services tailored towards PWUD and, 3. Willingness to take a COVID-19 test. The mean age was 44.1 years and 73 % were males. Fifty-four percent were injectors, and heroin/other opioids (35.8 %) and cocaine/amphetamine (25.2 %) were the most common main drugs used. Overall, 54.9 % were in opioid maintenance treatment (OMT). The majority (65.9 %) stated they knew the COVID-19 symptoms. Almost all the participants (91.2 %) reported they would take a COVID-19 test if experiencing relevant symptoms. The majority (63.7 %) were not aware of COVID-19 services available to PWUD. OMT patients were more likely to be familiar with COVID-19 symptoms (aOR = 3.4, 95 % CI 1.7; 6.8), and to be aware of COVID-19 services (aOR = 2.7, 95 % CI 1.1; 6.3). Overall, 35.4 % reported reduced drug availability, mainly for tranquilizers, while 61.5 % reported increased drug prices, mainly for cannabis. Drug treatment may play an important role in COVID-19 prevention, as those in OMT were more likely to be aware of symptoms and of availability of services.
DOI: 10.1111/add.14425
发表时间: 2019-01-01
期刊: ADDICTION
影响因子: 6
作者:
Madah-Amiri, Desiree;Gjersing, Linn;Clausen, Thomas
通讯作者: Clausen, Thomas
DOI: 10.1111/add.14053
发表时间: 2018-04-01
期刊: ADDICTION
影响因子: 6
作者:
Gjersing, Linn;Bretteville-Jensen, Anne Line
通讯作者: Bretteville-Jensen, Anne Line
DOI: 10.1111/j.1360-0443.2011.03463.x
发表时间: 2011-09-01
期刊: ADDICTION
影响因子: 6
作者:
Reimer, Jens;Verthein, Uwe;Haasen, Christian
通讯作者: Haasen, Christian
DOI: 10.32598/bcn.11.covid19.1
发表时间: 2020-03-01
影响因子: 1.7
作者:
Farhoudian, Ali;Baldacchino, Alexander;Razaghi, Emran Mohammad
通讯作者: Razaghi, Emran Mohammad
DOI: 10.2471/blt.12.108282
发表时间: 2013-02-01
影响因子: 11.1
作者:
Mathers, Bradley M;Degenhardt, Louisa;Hickman, Mathew
通讯作者: Hickman, Mathew